Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 29   

Articles published

GSK 1,671.50 -26.00 (-1.53%)
price chart
GlaxoSmithKline settles healthcare fraud case for $3 billion
A GlaxoSmithKline logo is seen outside one of its buildings in west London in this February 6, 2008 file photograph. GlaxoSmithKline Plc has agreed to plead guilty to criminal charges and pay $3 billion to settle the largest case of healthcare fraud in ...
GlaxoSmithKline to pay $3billion fine after pleading guilty to healthcare ...  Daily Mail
GlaxoSmithKline Is Actually A Decent Company Compared To Its Peers  Business Insider
GSK finalises $3bn takeover of HGS
GlaxoSmithKline is to acquire Human Genome Sciences for $3bn, bringing to an end a three-month hostile battle for control of the US biotech group best known for its pioneering drug for lupus.
GlaxoSmithKline to acquire Human Genome Sciences  Baltimore Sun (blog)
HGS Agrees to $3.6B GSK Buyout; Deal Inked at $14.25 Per Share  BioWorld Online
GlaxoSmithKline to pay $3 billion in fines, the largest health care fraud ...
The Justice Department said Monday that GlaxoSmithKline PLC will plead guilty to promoting popular antidepressants Paxil and Wellbutrin for unapproved uses.
Glaxo in $3 Billion Settlement  Wall Street Journal
GSK failed to act on illegal drug marketing  Financial Times
GSK clinches deal to buy Human Genome for $3 billion
LONDON/BOSTON GlaxoSmithKline Plc is to acquire its long-time partner Human Genome Sciences Inc for a sweetened offer of about $3 billion, ending on friendly terms a three-month hostile pursuit of the U.S.
3 UK Stocks With US-Style Dividends And No Tax Withholding For A Dividend ...
... British multinationals in three diverse sectors that pay American-style quarterly dividends that remain stable with consistent growth from year to year: Royal Dutch Shell PLC Class B (RDS.
Big Pharma is in big trouble – or at least it should be
Something is definitely wrong in their management and monitoring systems. GSK are not able to say that the activities for which they were fined were anything other than deliberate.
Glaxo Tries to Shake Marketing Questions on Advair
GlaxoSmithKline PLC's $3 billion criminal and civil settlement with the U.S. government this week raises questions about the future of asthma treatment Advair—the company's biggest moneymaker and one of the top-selling drugs in the world.
Healthcare: Into the cortex
“The challenge is to integrate the work - in brain-computer interfaces, materials science, nanotechnology, micro-power generation - to provide therapeutic benefit.
Stocks That Avoid Unrecoverable Foreign Dividend Withholding In Tax Deferred ...
U.S. investors can achieve some economic recapture of foreign tax withholding on their foreign dividend stocks through their U.S. tax returns.
Biovail Puts Up $37.5M To Ditch Wellbutrin Antitrust Case
The settlement, which does not involve fellow defendant GlaxoSmithKline PLC and remains subject to court approval, would end years of litigation accusing GSK and Biovail of trying to monopolize the market for Wellbutrin by blocking and impeding generic ...